RESUMEN
Identifying cell types and states remains a time-consuming, error-prone challenge for spatial biology. While deep learning is increasingly used, it is difficult to generalize due to variability at the level of cells, neighborhoods, and niches in health and disease. To address this, we developed TACIT, an unsupervised algorithm for cell annotation using predefined signatures that operates without training data. TACIT uses unbiased thresholding to distinguish positive cells from background, focusing on relevant markers to identify ambiguous cells in multiomic assays. Using five datasets (5,000,000-cells; 51-cell types) from three niches (brain, intestine, gland), TACIT outperformed existing unsupervised methods in accuracy and scalability. Integrating TACIT-identified cell types with a novel Shiny app revealed new phenotypes in two inflammatory gland diseases. Finally, using combined spatial transcriptomics and proteomics, we discovered under- and overrepresented immune cell types and states in regions of interest, suggesting multimodality is essential for translating spatial biology to clinical applications.
RESUMEN
ABSTRACT During the state of immune vulnerability in hematopoietic stem cell transplantation (HSCT), the patient has an increased risk of developing a vast number of complications, including severe problems in the oral cavity. These situations require professional oral care to act in the diagnosis and treatment of these conditions, as well as to develop prevention protocols to minimize patient's complications. Oral mucositis, opportunistic infections, bleeding, specific microbiota, taste, and salivary alterations are complications that can occur during HSCT and interfere with various aspects, such as pain control, oral intake, nutrition, bacteremia and sepsis, days of hospitalization and morbidity. Several guidelines have been published to address the role of professional oral care during the HSCT, we describe a consensus regarding these recommendations.
RESUMEN
ABSTRACT The oral involvement in the Hematopoietic Stem Cell Transplantation is well described in the literature. The goal of the dental treatment and management of the oral lesions related to the HSCT is to reduce the harm caused by preexisting oral infection or even the worsening of oral acute/chronic GVHD and late effects. The aim of this guideline was to discuss the dental management of patients subjected to HSCT, considering three phases of the HSCT: pre-HSCT, acute phase, and late phase. The literature published from 2010 to 2020 was reviewed in order to identify dental interventions in this patient population. The selected papers were divided into three groups: pre-HSCT, acute and late, and were reviewed by the SBTMO Dental Committee's members. When necessary, an expertise opinion was considered for better translating the guideline recommendations to our population dental characteristics. This manuscript focused on the pre-HSCT dental management. The objective of the pre-HSCT dental management is to identify possible dental situations that On behalf of the Dental Committee of the Brazilian Society of Gene Therapy and Bone Marrow Transplantation (SBTMO) can worsening during the acute phase after the HSCT. Each guideline recommendations were made considering the Dentistry Specialties. The clinical consensus on dental management prior to HSCT provides professional health caregivers with clinical setting-specific information to help with the management of dental problems in patients to be subjected to HSCT.
RESUMEN
ABSTRACT Patients undergoing hematopoietic stem cell transplantation (HSCT) might present acute and late toxicities and the oral tissues are frequently affected. With the survival increasing, patients show late and long-term morbidities, and there is an important association between the general and the oral health. The first and second parts of this Consensus have showed the importance of the adequacy of oral health in the pre-HSCT, and the main alterations and oral care during the period of admission for HSCT. This third part aims to review specific themes of post-HSCT dental care, such as graft-versus-host disease (GVHD) and the pediatric patient. It also aims to review pertinent subjects, both during the HSCT period and post-HSCT, concerning quality of life, pain, cost-effectiveness, and remote care. Based on this review, it is evident the importance of the work of the dental surgeon (DS) in the follow-up and treatment of the HSCT patient, always collaborating with the whole multidisciplinary team.
RESUMEN
OBJECTIVE: To identify oral characteristics found in children with liver disease in programming for liver transplantation. DATA SOURCE: The methodology was written according to PRISMA-ScR. We adopted the methodological framework and recommendations for this type of review by Arksey and O'Malley and the Joanna Briggs Institute. The protocol was registered in the Open Science Framework (https://doi.org/10.17605/OSF.IO/QCU4W). A systematic search (Medline/PubMed, Scopus, Web of Science, and ProQuest) was conducted to identify studies that met the inclusion criteria: systematic reviews; prospective clinical trials (parallel or crossover group designs); observational studies (cohort, case-control, and cross-sectional studies); clinical case series; and case reports evaluating children with liver disease in preparation for transplantation. The last search was conducted in July 2021, and no restrictions were imposed as to language or year of publication. Studies presenting mixed data with post-transplant evaluation, and studies evaluating not only liver transplantation but also other solid organs were excluded. Screening, inclusion, and data extraction were performed by two reviewers independently. A narrative synthesis was conducted to describe the findings of the study. DATA SYNTHESIS: The bibliographic search identified 830 references. A total of 21 articles were read in their entirety after the inclusion criteria assessment. Finally, after evaluating the exclusion criteria, only 3 studies were considered for the qualitative analysis. CONCLUSIONS: Children with liver disease in preparation for transplantation may present enamel defects, tooth pigmentation, caries, gingivitis, and opportunistic infections such as candidiasis.
Asunto(s)
Hepatopatías , Trasplante de Hígado , Niño , Humanos , Estudios Transversales , Estudios ProspectivosRESUMEN
Abstract Objective: To identify oral characteristics found in children with liver disease in programming for liver transplantation. Data source: The methodology was written according to PRISMA-ScR. We adopted the methodological framework and recommendations for this type of review by Arksey and O'Malley and the Joanna Briggs Institute. The protocol was registered in the Open Science Framework (https://doi.org/10.17605/OSF.IO/QCU4W). A systematic search (Medline/PubMed, Scopus, Web of Science, and ProQuest) was conducted to identify studies that met the inclusion criteria: systematic reviews; prospective clinical trials (parallel or crossover group designs); observational studies (cohort, case-control, and cross-sectional studies); clinical case series; and case reports evaluating children with liver disease in preparation for transplantation. The last search was conducted in July 2021, and no restrictions were imposed as to language or year of publication. Studies presenting mixed data with post-transplant evaluation, and studies evaluating not only liver transplantation but also other solid organs were excluded. Screening, inclusion, and data extraction were performed by two reviewers independently. A narrative synthesis was conducted to describe the findings of the study. Data synthesis: The bibliographic search identified 830 references. A total of 21 articles were read in their entirety after the inclusion criteria assessment. Finally, after evaluating the exclusion criteria, only 3 studies were considered for the qualitative analysis. Conclusions: Children with liver disease in preparation for transplantation may present enamel defects, tooth pigmentation, caries, gingivitis, and opportunistic infections such as candidiasis.
RESUMO Objetivo: Identificar características bucais em crianças hepatopatas em programação para o transplante hepático. Fontes de dados: A metodologia foi descrita de acordo com o PRISMA-ScR. Adotamos a estrutura metodológica e recomendações para este tipo de revisão por Arksey e O'Malley e o Instituto Joanna Briggs. O protocolo foi registrado no Open Science Framework (https://doi.org/10.17605/OSF.IO/QCU4W). Uma pesquisa sistemática (Medline/PubMed, Scopus, Web of Science e ProQuest) foi conduzida para identificar estudos que preenchessem os critérios de inclusão: revisões sistemáticas; ensaios clínicos prospectivos (desenhos de grupos paralelos ou cruzados); estudos observacionais (coorte, caso-controle e estudos transversais); séries de casos clínicos; e relatos de casos que avaliam crianças com doenças hepáticas em preparação para o transplante. A última busca foi conduzida em julho de 2021, e não foram impostas restrições quanto ao idioma ou ano de publicação. Foram excluídos estudos que apresentavam dados mistos com avaliação pós-transplante e estudos que avaliavam não só o transplante de fígado, mas também de outros órgãos sólidos. O rastreio, inclusão e extração de dados foram realizados por dois revisores independentemente. Foi conduzida uma síntese narrativa para identificar os resultados do estudo. Síntese dos dados: A pesquisa bibliográfica identificou 830 referências. Foram lidos 21 artigos na íntegra após avaliação dos critérios de inclusão. Finalmente, após a avaliação dos critérios de exclusão, apenas três estudos foram considerados para análise. Conclusões Crianças com doença hepática em preparação para o transplante podem apresentar defeitos de esmalte, pigmentação dentária, cárie, gengivite além de infecções oportunistas como a candidíase.
RESUMEN
OBJECTIVE: To assess the feasibility of using a new helmet interface for CPAP, designated ELMO, to treat COVID-19-related acute hypoxemic respiratory failure (AHRF) outside the ICU. METHODS: This was a proof-of-concept study involving patients with moderate to severe AHRF secondary to COVID-19 admitted to the general ward of a public hospital. The intervention consisted of applying CPAP via the ELMO interface integrated with oxygen and compressed air flow meters (30 L/min each) and a PEEP valve (CPAP levels = 8-10 cmH2O), forming the ELMOcpap system. The patients were monitored for cardiorespiratory parameters, adverse events, and comfort. RESULTS: Ten patients completed the study protocol. The ELMOcpap system was well tolerated, with no relevant adverse effects. Its use was feasible outside the ICU for a prolonged amount of time and was shown to be successful in 60% of the patients. A CPAP of 10 cmH2O with a total gas flow of 56-60 L/min improved oxygenation after 30-to 60-min ELMOcpap sessions, allowing a significant decrease in estimated FIO2 (p = 0.014) and an increase in estimated PaO2/FIO2 ratio (p = 0.008) within the first hour without CO2 rebreathing. CONCLUSIONS: The use of ELMOcpap has proven to be feasible and effective in delivering high-flow CPAP to patients with COVID-19-related AHRF outside the ICU. There were no major adverse effects, and ELMO was considered comfortable. ELMOcpap sessions significantly improved oxygenation, reducing FIO2 without CO2 rebreathing. The overall success rate was 60% in this pilot study, and further clinical trials should be carried out in the future.(ClinicalTrials.gov identifier: NCT04470258 [http://www.clinicaltrials.gov/]).
Asunto(s)
COVID-19 , Insuficiencia Respiratoria , Estudios de Factibilidad , Humanos , Unidades de Cuidados Intensivos , Proyectos Piloto , Prueba de Estudio Conceptual , Insuficiencia Respiratoria/terapia , SARS-CoV-2RESUMEN
ABSTRACT Objective: To assess the feasibility of using a new helmet interface for CPAP, designated ELMO, to treat COVID-19-related acute hypoxemic respiratory failure (AHRF) outside the ICU. Methods: This was a proof-of-concept study involving patients with moderate to severe AHRF secondary to COVID-19 admitted to the general ward of a public hospital. The intervention consisted of applying CPAP via the ELMO interface integrated with oxygen and compressed air flow meters (30 L/min each) and a PEEP valve (CPAP levels = 8-10 cmH2O), forming the ELMOcpap system. The patients were monitored for cardiorespiratory parameters, adverse events, and comfort. Results: Ten patients completed the study protocol. The ELMOcpap system was well tolerated, with no relevant adverse effects. Its use was feasible outside the ICU for a prolonged amount of time and was shown to be successful in 60% of the patients. A CPAP of 10 cmH2O with a total gas flow of 56-60 L/min improved oxygenation after 30-to 60-min ELMOcpap sessions, allowing a significant decrease in estimated FIO2 (p = 0.014) and an increase in estimated PaO2/FIO2 ratio (p = 0.008) within the first hour without CO2 rebreathing. Conclusions: The use of ELMOcpap has proven to be feasible and effective in delivering high-flow CPAP to patients with COVID-19-related AHRF outside the ICU. There were no major adverse effects, and ELMO was considered comfortable. ELMOcpap sessions significantly improved oxygenation, reducing FIO2 without CO2 rebreathing. The overall success rate was 60% in this pilot study, and further clinical trials should be carried out in the future. (ClinicalTrials.gov identifier: NCT04470258 [http://www.clinicaltrials.gov/])
RESUMO Objetivo: Avaliar a viabilidade do uso de uma nova interface do tipo capacete para CPAP, denominada ELMO, para o tratamento da insuficiência respiratória aguda (IRpA) hipoxêmica por COVID-19 fora da UTI. Métodos: Estudo de prova de conceito envolvendo pacientes com IRpA hipoxêmica moderada a grave secundária à COVID-19, internados na enfermaria geral de um hospital público. A intervenção consistiu na aplicação de CPAP por meio da interface ELMO integrada a fluxômetros de oxigênio e ar comprimido (30 L/min cada) e a uma válvula de PEEP (níveis de CPAP = 8-10 cmH2O), formando o sistema ELMOcpap. Os pacientes foram monitorados quanto a parâmetros cardiorrespiratórios, eventos adversos e conforto. Resultados: Dez pacientes completaram o protocolo do estudo. O sistema ELMOcpap foi bem tolerado, sem efeitos adversos relevantes. Seu uso foi viável fora da UTI por tempo prolongado e mostrou-se bem-sucedido em 60% dos pacientes. Uma CPAP de 10 cmH2O com fluxo total de gás de 56-60 L/min melhorou a oxigenação após sessões de ELMOcpap de 30-60 min, permitindo redução significativa da FIO2 estimada (p = 0,014) e aumento da PaO2/FIO2 estimada (p = 0,008) na primeira hora, sem reinalação de CO2. Conclusões: O uso do ELMOcpap mostrou-se viável e eficaz no fornecimento de CPAP de alto fluxo a pacientes com IRpA hipoxêmica por COVID-19 fora da UTI. Não houve nenhum efeito adverso importante, e o ELMO foi considerado confortável. As sessões de ELMOcpap melhoraram significativamente a oxigenação, reduzindo a FIO2 sem reinalação de CO2. A taxa global de sucesso foi de 60% neste estudo piloto, e novos ensaios clínicos devem ser realizados. (ClinicalTrials.gov identifier: NCT04470258 [http://www.clinicaltrials.gov/])
Asunto(s)
Humanos , Insuficiencia Respiratoria/terapia , COVID-19 , Proyectos Piloto , Estudios de Factibilidad , Prueba de Estudio Conceptual , SARS-CoV-2 , Unidades de Cuidados IntensivosRESUMEN
ABSTRACT: Some adjuvant treatments are available for Medication-Related Osteonecrosis of the Jaw (MRONJ) to help the pain and improve quality of life. Among these treatments is hyperbaric oxygen (HBO) which has presented controversial findings in the literature in recent years. This integrative review analyzed the results among studies published during the pas t 10 years using HBO. The PICO strategy was used and the databases PubMed, LILACS, and SCOPUS. The final search resulted in the inclusion of 7 articles. The main conclusion is that, in the majority of cases, using HBO as an adjuvant to the basic therapy improved the quality of life and/or pain of the patients.
RESUMEN: Existen algunos tratamientos adyuvantes para la osteonecrosis de la mandíbula relacionada con medicamentos (MRONJ) para aliviar el dolor y mejorar la calidad de vida de los pacientes. Entre estos tratamientos se encuentra el oxígeno hiperbárico (OHB) que ha presentado resultados controvertidos en la literatura durante los últimos años. En esta revisión integrada se analizaron los resultados de los estudios publicados durante los últimos 10 años utilizando OHB. Se utilizó la estrategia PICO y las bases de datos PubMed, LILACS y SCOPUS. La búsqueda final resultó en la inclusión de 7 artículos. La principal conclusión es que, en la mayoría de los casos, el uso de OHB como adyuvante de la terapia básica mejoró la calidad de vida y / o el dolor de los pacientes.
RESUMEN
Cerebellofaciodental syndrome is characterized by facial dysmorphisms, intellectual disability, cerebellar hypoplasia, and dental anomalies. It is an autosomal-recessive condition described in 2015 caused by pathogenic variants in BRF1. Here, we report a Brazilian patient who faced a diagnostic challenge beginning at 11 months of age. Fortunately, whole-exome sequencing (WES) was performed, detecting the BRF1 variants NM_001519.3:c.1649delG:p.(Gly550Alafs*36) and c.421C>T:p.(Arg141Cys) in compound heterozygosity, thus finally achieving a diagnosis of cerebellofaciodental syndrome. The patient is currently 25 years old and is the oldest patient yet reported. The clinical report and a review of published cases are presented. Atlanto-occipital fusion, a reduced foramen magnum and basilar invagination leading to compression of the medulla-spinal cord transition are skeletal findings not reported in previous cases. The description of syndromes with dental findings shows that such anomalies can be an important clue to relevant differential diagnoses. The cooperation of groups from different international centers made possible the resolution of this and other cases and is one of the strategies to bring medical advances to developing countries, where many patients with rare diseases are difficult to diagnose definitively.
Asunto(s)
Anomalías Múltiples/genética , Cerebelo/anomalías , Anomalías Craneofaciales/genética , Discapacidad Intelectual/genética , Atrofia Muscular/genética , Malformaciones del Sistema Nervioso/genética , Factores Asociados con la Proteína de Unión a TATA/genética , Anomalías Dentarias/genética , Anomalías Múltiples/diagnóstico por imagen , Anomalías Múltiples/fisiopatología , Adulto , Brasil/epidemiología , Cerebelo/diagnóstico por imagen , Cerebelo/fisiopatología , Niño , Preescolar , Anomalías Craneofaciales/diagnóstico por imagen , Anomalías Craneofaciales/fisiopatología , Discapacidades del Desarrollo/diagnóstico por imagen , Discapacidades del Desarrollo/genética , Discapacidades del Desarrollo/fisiopatología , Femenino , Predisposición Genética a la Enfermedad , Humanos , Lactante , Discapacidad Intelectual/diagnóstico por imagen , Discapacidad Intelectual/fisiopatología , Masculino , Atrofia Muscular/diagnóstico por imagen , Atrofia Muscular/fisiopatología , Malformaciones del Sistema Nervioso/diagnóstico por imagen , Malformaciones del Sistema Nervioso/fisiopatología , Anomalías Dentarias/diagnóstico por imagen , Anomalías Dentarias/fisiopatología , Secuenciación del ExomaRESUMEN
La anemia falciforme (AF) es un trastorno genético autosómico recesivo que afecta la hemoglobina y los glóbulos rojos adquieren una forma de hoz. Este evento provoca episodios de vaso-oclusión y hemólisis y, en consecuencia, una amplia gama de manifestaciones clínicas. Objetivo: realizar una revisión bibliográfica integrativa sobre el cuidado dental para pacientes con anemia falciforme. Materiales y Métodos: Se realizó una búsqueda en las bases de datos de PubMed y SciELO, utilizando como estrategia una asociación de tér-minos relacionados ("Anemia de Células Falciformes" y " Atención Odontológica"). Resultados: Se incluyeron los artículos publicados a partir de 1990 y se excluyeron revisiones de literatura, lo que resultó en dieciocho artículos para análisis. La evidencia científica demostró que la atención odontológica preventiva es esencial para los pacientes con anemia falciforme, ya que puede reducir el número de ingresos hospitalarios. Las me-didas previas, durante y posteriores al tratamiento pueden incluir profilaxis antibiótica, uso de sedación, buen control de los niveles de oxígeno, hidratación del paciente y mantenimiento de una perfusión tisular adecuada. Sin embargo, persisten algunas dudas, sobre la seguridad del uso de anestésicos locales con vasoconstric-tores y la oseointegración de implantes dentales. Conclusión: El conocimiento de la enfermedad es esencial para el tratamiento dental de pacientes con anemia falciforme; durante la atención, se debe tener en cuenta ciertos cuidados para reducir los factores que promueven crisis agudas como acidosis, hipotensión, hipoxia, infección, vasoconstricción y estrés.
Sickle cell anemia (SCA) is an autosomal recessive genetic disorder that affects the hemoglobin molecule of red blood cells in sickle-shaped cells formation. This event causes vasoocclusive crises and hemolysis, and consequently, a wide range of clinical manifestations. Objective: This study aimed to present an integrative review of the literature on dental care of patients with SCA. Material and Methods: A search was conducted in Pubmed and Scielo databases using as a search strategy an association of terms related to disease and dentistry ("Sickle Cell Anemia", "Dental Care"). Results: Studies published since 1990 were included while literature reviews were excluded, resulting in eighteen articles for analysis. The literature has shown that pre-ventive dental care is essential for patients with sickle cell anemia and is able to reduce the number of hospi-talizations. Pre, trans and post-treatment measures may include antibiotic prophylaxis, use of sedation, good control of oxygen levels, patient hydration, and maintenance of adequate tissue perfusion. Still, more studies are needed to clarify some dental uncertainties during the care given to patients with AF, such as the safety of local anesthetics with vasoconstrictors and the use of osseointegrated implants. Conclusion: The knowledge of the disease is essential for dental management. Certain precautions should be taken to reduce factors that promote acute crises, such as acidosis, hypotension, hypoxia, infection, vasoconstriction and stress.
A anemia falciforme (AF) é uma alteração genética autossômica recessiva que afeta a molécula de hemoglo-bina das hemácias, resultando na formação de células em forma de foice. Esse evento provoca episódios de vaso-oclusão e hemólise, e consequentemente, uma ampla gama de manifestações clínicas. Objetivo: Este trabalho teve como objetivo apresentar uma revisão integrativa de literatura sobre os cuidados odontológicos ao paciente com anemia falciforme. Materiais e Métodos: Foi conduzida uma busca nas bases de dados Pubmed e Scielo, utilizando-se como estratégia uma associação de termos relacionados à doença e à odon-tologia ("Anemia Falciforme" e "Assistência Odontológica"). Resultados: Foram incluídos artigos publicados a partir de 1990 e excluídas revisões de literatura, resultando em dezoito artigos para análise. A literatura mostrou que o atendimento odontológico preventivo é essencial para o paciente com anemia falciforme, sendo capaz de diminuir a quantidade de internações hospitalares. As medidas pré, trans e pós-tratamento podem incluir a profilaxia antibiótica, o uso de sedação, um bom controle dos níveis de oxigênio, a hidratação do paciente e a manutenção da perfusão tecidual adequada. No entanto, algumas dúvidas persistem como a segurança dos anestésicos locais com vasoconstritor e a instalação de implantes osseointegrados. Con-clusão: O conhecimento da doença é primordial para o manejo odontológico desses pacientes e, durante o atendimento, certos cuidados devem ser tomados para diminuir os fatores que promovem as crises agudas como a acidose, hipotensão, hipóxia, infecção, vasoconstrição e estresse.
Asunto(s)
Enfermedades Hematológicas , Hemoglobinopatías , Anemia de Células Falciformes , Atención Odontológica , Prevención Secundaria , Enfermedades Genéticas CongénitasRESUMEN
To establish the profile of patients who developed antiangiogenic agent-related osteonecrosis of the jaws, and identify the treatments currently used in dental management. We searched the PubMed®/Medline® and Scopus databases using the words "osteonecrosis AND antiangiogenic therapy", with the following inclusion criteria: articles published in English, case reports, available online, and for an unlimited period. Of the 209 articles retrieved, 18 were selected, for a total of 19 case reports, since one article included two cases that met the inclusion criteria for this study. Medication-related osteonecrosis of the jaws is characterized by exposure of necrotic bone in the oral cavity that does not heal over a period of 8 weeks in patients with no previous history of radiation therapy. Antiangiogenic drugs are indicated in the treatment of certain tumors, since they stop the formation of new blood vessels, controlling tumor growth and the chance of metastasis. Dental prevention is essential in patients who will be put on antiangiogenic agents, to minimize the risk for osteonecrosis.
Asunto(s)
Inhibidores de la Angiogénesis/efectos adversos , Enfermedades Maxilomandibulares/inducido químicamente , Osteonecrosis/inducido químicamente , Femenino , Humanos , Masculino , Factores de RiesgoRESUMEN
Cirurgiões-dentistas habilitados em práticas baseadas em evidências científicas e na aplicação de modelos de cuidados em saúde bucal bem-sucedidos trazem benefícios tanto à saúde individual quanto à coletiva. Este estudo traçou um panorama sobre cursos de Habilitação em Odontologia Hospitalar ofertados no Brasil após a regulamentação da Resolução 162/2015 pelo Conselho Federal de Odontologia (CFO), para auxiliar a escolha dos profissionais que pretendem se habilitar na área. O método de pesquisa foi a revisão integrativa da literatura, com análise quantitativa, exploratória e descritiva dos dados. O modelo de busca aplicado foi "habilitação em odontologia hospitalar", na base de dados Google, com uma única consulta em março de 2019. Dezessete (17) propostas foram encontradas. Seguiram para análise treze (13) propostas que informavam número de vagas ofertadas, periodicidade do curso, dias da semana em que ocorriam as atividades, carga horária total, conteúdo programático (teórico e prático) e local da prática. Falta de conteúdo programático (n=2) e de atualização (n=1) foram critérios de exclusão imediata. Na análise descritiva das propostas (n=10) houve exclusões por falta de definição da carga horária teórica e prática (n=4); informação sobre o conteúdo prático (n=5) e de identificação do local de desenvolvimento e carga horária mínima exigida para a prática. O estudo evidenciou que, à época da coleta de dados, apenas uma proposta atendia à legislação e à normativa exigidas pelo CFO (AU).
Dentists qualified on evidence-based practices and on the application of successful oral health care models are beneficial to individual and collective health. The current study presents an overview of Hospital Dentistry Qualification courses available in Brazil after the regulation of Resolution 162/2015 by the Conselho Federal de Odontologia (CFO - Brazil), which focuses on assisting the selection by professionals who intend to qualify in this field. Integrative literature review, with quantitative, exploratory and descriptive data analyses, was the research method adopted in the present study. The mesh "hospital dentistry qualification" was used in the single search conducted on Google database, in March 2019. Seventeen (17) proposals were found. Thirteen (13) proposals that included information about vacancies available for students, course periodicity, weekdays when the course took place, total workload, program content (theoretical and practical) and place of practice were selected for analysis. Lack of program content (n=2) and outdated information (n=1) were immediate exclusion criteria. The descriptive analysis applied to the proposals (n=10) has shown that courses were excluded due to lack of definition ofthe workload of theoretical and practical activities (n=4); as well as of information about the practical content of the course (n=5), the hospital where the practice would take place and the minimum workload required for the practice. One (01) qualification proposal was included in the research based on qualitative synthesis. The current study has shown that one proposal was in compliance with the legislation and regulations required by FCD, as well as that the presentation of the information available in the website about the proposal makes it hard for the target audience to make the option for the course that would best meet their needs (AU).
Asunto(s)
Servicio Odontológico Hospitalario , Personal de Odontología en Hospital , Capacitación de Recursos Humanos en Salud , Necesidades y Demandas de Servicios de Salud , Hospitales , Redes de Comunicación de Computadores , Brasil/epidemiología , Salud Bucal , Epidemiología Descriptiva , Encuestas y Cuestionarios , Odontólogos , Estudios de Evaluación como AsuntoRESUMEN
This review aimed to analyze the scientific production on severity of oral mucositis as an adverse effect of chemotherapy. To this end, we performed a search at PubMed databases combining the keywords "oral mucositis" and "chemotherapy protocol". To describe the investigation, the following variables were considered: journal, year/place, study design, sample, protocol used and incidence of oral mucositis. A total of 547 articles were retrieved, of which 26 were selected. Out of these 26, only 2 reported severity of oral mucositis; the others only reported the presence of the condition. Protocols for treating different types of carcinoma were evaluated in 16 (61.53%) studies, for hematological malignancies in 6 (23.07%), and for hematopoietic stem cell transplantation in 4 (15.4%). Protocols for hematopoietic stem cell transplantation entail a high risk for oral mucositis, just as chemotherapy with cytarabine and high-dose 5-fluorouracil, alkylating agents and platinumbased compounds. To provide the best prevention and treatment for oral mucositis, it is essential to know the chemotherapy protocols used and their effects on the oral cavity.
Asunto(s)
Antineoplásicos/efectos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Estomatitis/inducido químicamente , HumanosRESUMEN
ABSTRACT This review aimed to analyze the scientific production on severity of oral mucositis as an adverse effect of chemotherapy. To this end, we performed a search at PubMed databases combining the keywords "oral mucositis" and "chemotherapy protocol". To describe the investigation, the following variables were considered: journal, year/place, study design, sample, protocol used and incidence of oral mucositis. A total of 547 articles were retrieved, of which 26 were selected. Out of these 26, only 2 reported severity of oral mucositis; the others only reported the presence of the condition. Protocols for treating different types of carcinoma were evaluated in 16 (61.53%) studies, for hematological malignancies in 6 (23.07%), and for hematopoietic stem cell transplantation in 4 (15.4%). Protocols for hematopoietic stem cell transplantation entail a high risk for oral mucositis, just as chemotherapy with cytarabine and high-dose 5-fluorouracil, alkylating agents and platinumbased compounds. To provide the best prevention and treatment for oral mucositis, it is essential to know the chemotherapy protocols used and their effects on the oral cavity.
RESUMO Esta revisão teve como objetivo analisar a produção científica sobre a gravidade da mucosite oral como efeito adverso da quimioterapia. Para tal, nos bancos de dados do PubMed, foi realizada uma busca com a associação dos descritores "oral mucositis" com "chemotherapy protocol". Para descrição da investigação, foram consideradas como variáveis: periódico, ano/local, delineamento da pesquisa, amostra, protocolo utilizado e incidência de mucosite oral. Foram analisados 547 artigos e, destes, 26 foram selecionados. Destes 26, apenas 2 tinham como objetivo avaliar a gravidade de mucosite oral; nos outros, a mucosite oral foi apenas relatada. Protocolos para tratamento de diferentes tipos de carcinoma foram avaliados em 16 (61,53%) estudos, para neoplasias hematológicas, em 6 (23,07%), e para transplante de células tronco hematopoiéticas em 4 (15,4%). Protocolos para transplante de células tronco hematopoiéticas são de alto risco para o desenvolvimento de mucosite oral, da mesma forma que os quimioterápicos citarabina e 5-fluorouracil em altas doses, agentes alquilantes e compostos derivados da platina. A fim de oferecer prevenção e tratamento mais adequados para mucosite oral, é imprescindível que se conheçam os protocolos quimioterápicos utilizados e seus efeitos sobre a cavidade oral.
Asunto(s)
Humanos , Estomatitis/inducido químicamente , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Antineoplásicos/efectos adversosRESUMEN
Objetivo: realizar uma reflexão sobre a aplicação dos princípios bioéticos na atuação do cirurgião-dentista em âmbito hospitalar. Material e Métodos: uma revisão crítica da literatura foi realizada acessando-se as bases de dados PubMed, Scielo e Biblioteca Virtual em Saúde, utilizando-se os descritores "Bioética", "Equipe Hospitalar de Odontologia", "Ética Odontológica" e "Ética Institucional". Resultados: não foram encontrados estudos específicos sobre o tema proposto. Há escassez de trabalhos na literatura científica específicos sobre a aplicação dos princípios bioéticos ao dia a dia dos profissionais de Odontologia em âmbito hospitalar. Conclusão: a observância e o respeito aos pilares bioéticos da autonomia, justiça, beneficência e não maleficência devem estar incluídos nas atitudes do cirurgião-dentista e da equipe multiprofissional, minimizando os desconfortos ocasionados por problemas de ordem geral e bucal.
Objective: to reflect on the application of the basic principles of bioethics in the performance of the dentist in a hospital environment. Materials and Methods: a critical review of the scientific literature was performed by searching the PubMed, Scielo, and Virtual Health Library databases using the descriptors "Bioethics," "Dental Staff, Hospital," "Ethics, Dental" and "Ethics, Institutional." Results: there were no specific studies on the proposed theme. There was a lack of studies in the scientific literature on the specific application of the bioethical principles in the routine of dental professionals at hospitals. Conclusion: the observance and respect for the bioethical pillars of autonomy, justice, beneficence and non-maleficence must be included in the attitudes of the dentist and the multidisciplinary team, minimizing the discomforts caused by problems of general and oral disorders.
RESUMEN
Objetivo: O objetivo deste artigo foi revisar os dados na literatura sobre possíveis mecanismos que estabeleçam uma relação entre o câncer oral e a doença periodontal. Material e Métodos: Foi realizada uma busca nas bases de dados Pubmed, Scopus e Web of Science por publicações até abril de 2016. Resultados: Os artigos analisados apontaram evidências que corroboram com o papel da doença periodontal na carcinogênese. Esta atuação baseia-se na liberação de mediadores inflamatórios e de periodontopatógenos das bolsas periodontais até sítios sadios através do sangue e da saliva, sendo capaz alterar o padrão epigenético do hospedeiro. Em consequência, esta alteração na expressão gênica pode inibir regiões relacionadas à supressão tumoral, crescimento celular, reparo do DNA, ligação intracelular, inibição de metástase, entre outros. Conclusão: É possível concluir que há bases biológicas para sustentar uma relação entre doença periodontal e o câncer oral, porém mais estudos são necessários para avaliar seu real impacto
Objective: The aim of this article was to review the extant literature about possible mechanisms for a relationship between periodontal disease and oral cancer. Material and Methods: A search was performed using PubMed, Scopus, and Web of Science for articles published through April 2016. The articles showed evidence supporting the role of periodontal disease in carcinogenesis. Results: The relationship between periodontal disease and oral cancer is based on the release of inflammatory mediators and periodontopathogens from periodontal pockets to healthy sites via the blood and saliva, thereby changing the host's epigenetic patterns. Consequently, these changes in gene expression can inhibit genetic regions related to tumor suppression, cell growth, DNA repair, intracellular binding, and inhibition of metastasis, among other processes. Conclusion: There is sufficient biological evidence to support the relationship between periodontal disease and oral cancer; however, more studies are needed to evaluate the impact of this relationship on patients
RESUMEN
Objetivo: Avaliar a efetividade das substâncias lubrificantes bucais Biotène Oral Balance® (Laclede do Brasil Produtos Médicos e Odontológicos Ltda, Cotia, Brasil) e Biotène Mouthwash® (Laclede do Brasil Produtos Médicos e Odontológicos Ltda, Cotia, Brasil) em indivíduos com epidermólise bolhosa. Métodos: Participaram deste estudo 10 indivíduos com epidermólise bolhosa, 7 do sexo feminino e 3 do masculino, com idades entre 7 a 30 anos. Foi aplicada a Escala Visual Analógica em dois momentos: pré-tratamento e um mês após o uso contínuo das substâncias descritas, e em três situações: higiene bucal, alimentação e procedimentos odontológicos. A comparação dos resultados entre os dois momentos em cada situação foi realizada pelo teste não-paramétrico de Wilcoxon, com nível de significância fixado em 5%. Resultados: Para a higiene bucal observou-se diferença significante entre os momentos pré-tratamento e uso contínuo das substâncias descritas (p=0,011), apresentando pré-tratamento valores da Escala Visual Analógica significantemente maiores com relação ao uso contínuo das substâncias descritas. Em relação à alimentação e procedimentos odontológicos não foram observados diferenças significantes nos momentos avaliados (p=0,180 e 0,672, respectivamente). Conclusão: Concluiu-se que o uso de substâncias lubrificantes orais em indivíduos com epidermólise bolhosa é efetivo na higienização oral, reduzindo a intensidade dolorosa durante o ato.
Objective: This study assessed the effectiveness of the oral lubricants Biotène Oral Balance® and Biotène Mouthwash® in individuals with epidermolysis bullosa. Methods: Ten individuals with epidermolysis bullosa participated in this study, 7 females and 3 males, aged 7 to 30 years. The Visual Analogue Scale was used on two occasions (before treatment (M1) and one month after regular use of the abovementioned substances (M2)) and in three situations (oral hygiene, diet and dental procedures). The non-parametric Wilcoxon test was used to compare the results between the two occasions with significance set at 5%. Results: Oral hygiene before and after treatment with either substance differed significantly (p=0.011). The values obtained by the Visual Analogue Scale were significantly higher before treatment. Diet and dental procedures did not differ significantly between occasions (p=0.180 and 0.672, respectively). Conclusion: Oral lubricants effectively reduced the pain experienced by individuals with epidermolysis bullosa during oral hygiene.